Nevro Corp
NVRO
Get informed when a big investor buys or sells
+ FollowMarket Cap$224.09M
Close$
$14.29
144.6% upside
Current Fair Value
144.6% upsideUndervalued by 144.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $224.09 Million |
|---|---|
| Enterprise Value | $382.43 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.06 |
| Beta | 0.82 |
| Outstanding Shares | 37,616,374 |
Return
| Return on Equity | -49.11% |
|---|---|
| Return on Assets | -20.48% |
| Return on Invested Capital | -25.88% |
Valuation & Multiples
| P/E Ratio | -1.91 |
|---|---|
| PEG | -0.39 |
| Price to Sales | 0.58 |
| Price to Book Ratio | 0.97 |
| Enterprise Value to Revenue | 0.94 |
| Enterprise Value to EBIT | -3.28 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.66 |
| Debt to Equity | 1.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 10, 2025
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Nevro Corp
CEO: D.Keith Grossman Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and c...